|
RAB5B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.817500E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.504100E-03 |
| Normal-vs-Stage2 |
1.731000E-01 |
| Normal-vs-Stage3 |
9.755000E-04 |
| Normal-vs-Stage4 |
6.239100E-03 |
| Stage1-vs-Stage2 |
3.737400E-01 |
| Stage1-vs-Stage3 |
4.120800E-01 |
| Stage1-vs-Stage4 |
7.364000E-01 |
| Stage2-vs-Stage3 |
1.496170E-01 |
| Stage2-vs-Stage4 |
3.023600E-01 |
| Stage3-vs-Stage4 |
7.743800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.597320E-03 |
| Normal-vs-AfricanAmerican |
1.923830E-01 |
| Normal-vs-Asian |
7.956400E-03 |
| Caucasian-vs-AfricanAmerican |
5.144000E-01 |
| Caucasian-vs-Asian |
9.955200E-01 |
| AfricanAmerican-vs-Asian |
4.760800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.979700E-03 |
| Normal-vs-Female |
1.880660E-03 |
| Male-vs-Female |
7.824800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.017000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.168060E-02 |
| Normal-vs-Age(61-80Yrs) |
1.015540E-03 |
| Normal-vs-Age(81-100Yrs) |
1.438370E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.689800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.637000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.687200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.258800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.194400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.706600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.221600E-01 |
| Classical-VS-Follicular |
6.907200E-01 |
| Classical-VS-Other |
4.255400E-01 |
| Classical-VS-Normal |
1.455820E-02 |
| Tall-VS-Follicular |
5.421000E-01 |
| Tall-VS-Other |
7.577600E-01 |
| Tall-VS-Normal |
8.319400E-03 |
| Follicular-VS-Other |
6.305800E-01 |
| Follicular-VS-Normal |
2.643900E-02 |
| Other-VS-Normal |
7.229800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.720930E-03 |
| Normal-vs-N1 |
1.388550E-04 |
| N0-vs-N1 |
1.512370E-01 |
|
|
